Insider Trends: Insider at Exelixis Awarded Shares Uses Portion to Pay Taxes, Slowing 90-Day Buy Trend
10:48 PM EST, 02/05/2021 (MT Newswires) -- On Feb 03, 2021, Christopher J Senner, EVP & CFO, awarded 69,156 shares in Exelixis (EXEL) and sold 18,206 shares concurrently to meet tax obligations. After accounting for tax obligations this transaction resulted in a net acquisition of 50,950 company shares. Subsequent to the Form 4 filing with the SEC, Senner has control over 299,269 shares of the company of which 296,546 shares are held directly and 2,723 are controlled indirectly. These holdings have an approximate market value of $6.86 million as of the prior-day closing price.
During the most recent 90-day period, previous to the date of this filing, there have been 21 insider transactions reported to the SEC for Exelixis. These transactions came from the activities of 8 individual insiders that resulted in a net acquisition of 22,881 company shares. This compares with the preceding 90-day window of time where there were 28 transactions from 8 insiders and resulted in the net acquisition of 279,727 shares.
This represents a lower level of transactions than the peer group average in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Peer group activity averaged 56.3 transactions per company, with company insiders acquiring on average 24,490 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/939767/000093976721000008/xslF345X03/wf-form4_161257763546589.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.